← FDA DRUG APPROVALS

FDA ANDA · ANDA072429

FENOPROFEN CALCIUM

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA072429
TYPE
ANDA
ORIGINAL APPROVAL
1988-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FENOPROFEN CALCIUMDiscontinued
FENOPROFEN CALCIUM EQ 600MG BASE · TABLET · ORAL

Approval history

2024-11-21Labeling · Supplement 9 · standardAP
2021-04-28Labeling · Supplement 8 · standardAP
1994-04-21Manufacturing (CMC) · Supplement 5AP
1991-05-31Labeling · Supplement 7AP
1989-09-07Bioequivalence · Supplement 6AP
1989-05-12Labeling · Supplement 4AP
1989-03-31Labeling · Supplement 3AP
1988-07-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →